Atlas Trials

Eflornithine in Treating Patients With Bladder Cancer

Clinical trial NCT00003814 · COMPLETED

Trial details

NCT number
NCT00003814
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
1999-02-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.